title: Corrigendum to: miR-30e targets IGF2-regulated osteogenesis in bone marrow-derived mesenchymal stem cells, aortic smooth muscle cells, and ApoE-/- mice.
abstract: [Cardiovasc Res 2015; 106(1):131–142] There were some references to the reported concentration of a standard reagent used which were incorrect. This does not affect the conclusion of the paper in any way but the author would like to amend this. It is shown correctly below and has also been corrected online. The authors apologise for this error. In Figure 4 the legend, 500 mg/ml should be substituted with 500 ng/ml.In section 3.8 IGF2 recombinant protein rescues miR-30e-repressed osteogenesis in SMCs there are two unit errors; one is 500 mg/ml should be corrected to 500 ng/ml; the second is 250 mg/ml should be corrected to 250 ng/ml.